InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.70
(
0.13%
)
US TECH 100
17,618.80
(
0.05%
)
Dow Jones
38,884.26
(
0.08%
)
Brent Oil
82.57
(
-0.36%
)
Bitcoin
62,324.97
(
-0.02%
)
Post# of 257
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

MWM

Send PM Follow Ignore
Followers 1062
Posts 141580
Boards Moderated 14
Alias Born 03/31/2006

MWM

Re: None

Monday, 03/07/2011 10:14:58 PM

Monday, March 07, 2011 10:14:58 PM

Post# of 257
Laxai Pharma (formerly NexGen Biofuels) has given up its flirtation with ethanol for its first love, clinical research services. Under the name Healthcare Technologies, the company once made diagnostic tests and other tools for clinical labs and biotech researchers. But in early 2008 it divested its diagnostics operations and acquired the assets of NexGen Biofuels and taking its name, planned to build several ethanol and bio-diesel plants in the US. However, in 2009 the company had a change of heart and decided to go back to its first business, and in 2010 acquired OSR Solutions, a drug development company. Laxai Pharma's strategic plans call for it to acquire other clinical research services firms.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up